IP Verse

Biofrontera Inc. et al. vs DUSA Pharmaceuticals, Inc. et al.

The detailed information for PTAB case with proceeding number IPR2022-00056 filed by Biofrontera Inc. et al. against DUSA Pharmaceuticals, Inc. et al. on Oct 19, 2021. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2022-00056
Filing Date: Oct 19, 2021
Petitioner: Biofrontera Inc. et al.
Respondent: DUSA Pharmaceuticals, Inc. et al.
Status: Terminated
Respondent Application Number: 15869164
Respondent Tech Center: 3700
Respondent Patent Number: 10357567
Termination Date: Jan 24, 2022

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Notice: refund approved	Jan 31, 2022	PAPER	BOARD
Request for Refund of Post-Institution Fees	Jan 28, 2022	PAPER	PETITIONER
Termination Decision: Pre-DI dismissal	Jan 24, 2022	PAPER	BOARD
Renewed Unopposed Motion to Dismiss Petition for Inter Partes Review	Jan 18, 2022	PAPER	PETITIONER
Confidential Settlement and Release Agreement	Jan 18, 2022	EXHIBIT	PETITIONER
Joint Request that Settlement Agreement Be Treated as Business Confidential Information and Be Kept Separate Pursuant to 35 U.S.C. �� 317(b) and 37 C.F.R. �� 42.74(c)	Jan 18, 2022	PAPER	PETITIONER
Denying, without Prejudice, Petitioner Motion to Dismiss the Petition 37 C.F.R. §§ 42.5(a), 42.71(a), 42.74(b)	Dec 28, 2021	PAPER	BOARD
Unopposed Motion to Dismiss Petition for Inter Partes Review	Dec 3, 2021	PAPER	PETITIONER
Patent Owner's Mandatory Notices	Nov 9, 2021	PAPER	PATENT OWNER
Patent Owner's Power of Attorney	Nov 9, 2021	PAPER	PATENT OWNER
Notice: Notice filing date accorded	Oct 29, 2021	PAPER	BOARD
Petition for Inter Partes Review Under 35 U.S.C. 312	Oct 19, 2021	PAPER	PETITIONER
Petitioner's Power of Attorney	Oct 19, 2021	PAPER	PETITIONER
U.S. Patent No. 10,357,567	Oct 19, 2021	EXHIBIT	PETITIONER
Excerpts from U.S. Patent Application No. 15/869,164	Oct 19, 2021	EXHIBIT	PETITIONER
Declaration of Dr. Howard Rogers MD, PHD	Oct 19, 2021	EXHIBIT	PETITIONER
CV of Dr. Howard Rogers MD, PHD	Oct 19, 2021	EXHIBIT	PETITIONER
PCT Publication No. WO 96/06602 (Noven Pharma)	Oct 19, 2021	EXHIBIT	PETITIONER
Sakamoto FH, Torezan L, Anderson RR. Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part II. Understanding parameters for acne treatment with photodynamic therapy. J Am Acad Dermatol. 2010 Aug;63(2):195-211	Oct 19, 2021	EXHIBIT	PETITIONER
Berardesca E, Vignoli GP, Fideli D, Maibach H. Effect of occlusive dressings on the stratum corneum water holding capacity. The American Journal of the Medical Sciences. 1992 Jul;304(1):25-28	Oct 19, 2021	EXHIBIT	PETITIONER
Fauteck JD, Ackermann G, Birkel M, Breuer M, Moor AC, Ebeling A, Ortland C. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses.	Oct 19, 2021	EXHIBIT	PETITIONER
U.S. Patent Publication No. US2009/0324727 A1 (Biofrontera)	Oct 19, 2021	EXHIBIT	PETITIONER
Ameluz�� Prescribing Information (2016)	Oct 19, 2021	EXHIBIT	PETITIONER
Levulan�� Label (2002)	Oct 19, 2021	EXHIBIT	PETITIONER
Blu-U�� Operating Manual (2006)	Oct 19, 2021	EXHIBIT	PETITIONER
Willey A, Anderson RR, Sakamoto FH. Temperature-modulated photodynamic therapy for the treatment of actinic keratosis on the extremities. Dermatologic Surgery. 2014 Oct;40(10):1094- 1102	Oct 19, 2021	EXHIBIT	PETITIONER
Calderhead RG. Light-emitting diode phototherapy in dermatological practice in lasers in dermatology and medicine. Lasers in Dermatology and Medicine. 2011 Aug:231-265	Oct 19, 2021	EXHIBIT	PETITIONER
Palm M., Goldman PM. Aminolevulinic acid: actinic keratosis and photorejuvenation. In: Gold M.H., editor. Photodynamic Therapy in Dermatology. Springer Science and Business Media, LLC. 2011 Nov:5-30	Oct 19, 2021	EXHIBIT	PETITIONER
MacCormack MA. Photodynamic therapy in dermatology: an update on applications and outcomes. Semin Cutan Med Surg. 2008 Mar;27(1):52-62	Oct 19, 2021	EXHIBIT	PETITIONER
Sotiriou E, Apalla Z, Maliamani F, Zaparas N, Panagiotidou D, Ioannides D. Intraindividual, right-left comparison of topical 5- aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.	Oct 19, 2021	EXHIBIT	PETITIONER
Bissonnette R. Photodynamic therapy. In: Gold M.H., editor. Photodynamic Therapy in Dermatology. Springer Science and Business Media, LLC; New York, NY, USA: 2011. pp. 221��229	Oct 19, 2021	EXHIBIT	PETITIONER
McLaren G. Photodynamic therapy. In; Pfenninger and Fowler's procedures for primary care. Third Ed. Mosby Elsevier; Philadelphia, PA: 2011. pp 397-400	Oct 19, 2021	EXHIBIT	PETITIONER
Harris DR. Percutaneous absorption and the surface area of occluded skin: a scanning electron microscopic study. British Journal of Dermatology. 1974; 91(27-32)	Oct 19, 2021	EXHIBIT	PETITIONER
Levulan�� Label (2009)	Oct 19, 2021	EXHIBIT	PETITIONER
Wachowska et al., Aminolevulinic acid (ALA) as a prodrug in photodynamic therapy of cancer. Molecules. 2011 May; 16(5): 4140-4164	Oct 19, 2021	EXHIBIT	PETITIONER
Agostinis et al. Photodynamic therapy of cancer: an update. CA: A Cancer Journal for Clinicians. 2011 May; 61(4):250-2	Oct 19, 2021	EXHIBIT	PETITIONER
Wolf P., Rieger E. and Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5- aminolevulinic acid: an alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?	Oct 19, 2021	EXHIBIT	PETITIONER
Jeffes E., McCullough J., Weinstein G., Fergin P., Nelson J., Shull T., Simpson K., Bukaty L., Hoffman W., Fong N. Photodynamic therapy of actinic keratosis with topical 5- aminolevulinic acid. A pilot dose-ranging study. Arch Dermatol. 1997	Oct 19, 2021	EXHIBIT	PETITIONER
Hongcharu W., Taylor C., Chang, Y., Aghasi, D., Suthamjariya, K., Anderson, R. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol. 2000 Aug;115(2):183-92	Oct 19, 2021	EXHIBIT	PETITIONER
Ozog, D., Rkein, A., Fabi, S., Gold M., Goldman, M., Lowe, N., Martin, G., Munavalli, G. Photodynamic therapy: A clinical consensus guide. Dermatol Surg. 2016 Jul;42(7):804-27	Oct 19, 2021	EXHIBIT	PETITIONER
Aktilite CL128 Operators Manual with Metvixia	Oct 19, 2021	EXHIBIT	PETITIONER
DUSA Levulan Press Release	Oct 19, 2021	EXHIBIT	PETITIONER
European Medicines Agency CHMP Assessment Report (excerpts)	Oct 19, 2021	EXHIBIT	PETITIONER
Affidavit of Duncan Hall	Oct 19, 2021	EXHIBIT	PETITIONER
Willey Pubmed Website Database Listing	Oct 19, 2021	EXHIBIT	PETITIONER
Sotiriou Pubmed Website Database Listing	Oct 19, 2021	EXHIBIT	PETITIONER
Fauteck Europe PMC Website Database Listing	Oct 19, 2021	EXHIBIT	PETITIONER
Rick K, Sroka R, Stepp H, Kriegmair M, Huber RM, Jacob K, Baumgartner R. Pharmacokinetics of 5-aminolevulinic acidinduced protoporphyrin IX in skin and blood. J Photochem Photobiol B. 1997 Oct;40(3):313-9	Oct 19, 2021	EXHIBIT	PETITIONER
International Patent Reviews, LLC review of U.S. Patent No. 10,357,567 dated July 26, 2021	Oct 19, 2021	EXHIBIT	PETITIONER
News article entitled DUSA Pharmaceuticals To Pay U.S. $20.75 Million To Settle False Claims Act Allegations Relating To Promotion Of Unsupported Drug Administration Process	Oct 19, 2021	EXHIBIT	PETITIONER